BioNxt Solutions Inc.
BNXTF
$0.3747
$0.0257.15%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1,288.89% | -70.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1,288.89% | -70.97% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 1,288.89% | -70.97% | |||
| SG&A Expenses | 99.25% | -52.70% | |||
| Depreciation & Amortization | 1.20% | -2.91% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 86.29% | -47.34% | |||
| Operating Income | -84.20% | 47.25% | |||
| Income Before Tax | -50.93% | 39.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -50.93% | 39.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -50.93% | 39.00% | |||
| EBIT | -84.20% | 47.25% | |||
| EBITDA | -86.92% | 48.03% | |||
| EPS Basic | -46.15% | 39.25% | |||
| Normalized Basic EPS | -43.90% | 38.81% | |||
| EPS Diluted | -46.15% | 39.25% | |||
| Normalized Diluted EPS | -43.90% | 38.81% | |||
| Average Basic Shares Outstanding | 2.98% | 0.69% | |||
| Average Diluted Shares Outstanding | 2.98% | 0.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
